Effects of fasting during the month of Ramadan on renal function in patients with autosomal dominant polycystic kidney disease

被引:15
|
作者
Ekinci, Iskender [1 ]
Erkoc, Reha [2 ]
Gursu, Meltem [2 ]
Dogan, Elif Ece [1 ]
Kilic, Elif [3 ]
Cebeci, Egemen [4 ]
Ozturk, Savas [4 ]
Kazancioglu, Rumeyza [2 ]
机构
[1] Bezmialem Vakif Univ, Dept Internal Med, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Dept Nephrol, Istanbul, Turkey
[3] Bezmialem Vakif Univ, Dept Biochem, Istanbul, Turkey
[4] Haseki Training & Res Hosp, Dept Nephrol, Istanbul, Turkey
关键词
acute renal injury; autosomal dominant polycystic kidney disease; proteinuria; blood pressure; TRANSPLANT RECIPIENTS; BLOOD-PRESSURE; WATER-INTAKE; PHYSIOLOGY; INJURY; RISK; BODY; CKD;
D O I
10.5414/CN109102
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In this study, we aimed to examine the impact of fasting during the month of Ramadan on autosomal dominant polycystic kidney disease (ADPKD) patients with normal to near-nomial glomerular filtration rate (GFR). Materials and methods: This was a prospective observational study of patients with ADPKD, the majority of whom had normal or near-normal GFR. Patients were divided into two groups: the fasting group (FG) and the nonfasting group (NFG). Assessments in the NFG were performed 1 week before and 1 month after Ramadan. while FG patients were assessed on the last day of fasting in addition to the abovementioned visits. The following parameters were checked at each visit: blood pressure (BP), weight, sodium. potassium, blood urea nitrogen (BUN), creatinine, calcium. phosphorus, glucose, lipid profile. bicarbonate, urine density. 24-hour urine volume, 24-hour urine protein, GFR, neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1). Kidney function tests were carried out on the 7th day of fasting in the FG for the identification of early kidney damage. Results: Of the overall group of 54 patients. 23 were in FG (19 female) and 31 were in NFG (18 female). There were no significant differences between the two groups in terms of age, gender, ADPKD duration, and presence of hypertension. The mean estimated glomerular filtration rate (eGFR) values of FG and NFG were 86.4 +/- 18.5 and 66.1 +/- 36.5 mL/min/1.73m(2), respectively. During the follow-up period. no significant changes occurred in BR weight, creatinine, 24-hour urine volume. NGAL, KIM-1, or GFR in either group (p > 0.05), while 24-hour urinaly protein was significantly decreased in FG (p < 0.001). Conclusion:. A fasting duration of similar to 17 hours a day did not affect renal function negatively in patients with early-stage chronic kidney disease due to ADPKD. Also, no significant changes occurred in acute renal failure markers.
引用
收藏
页码:103 / 112
页数:10
相关论文
共 50 条
  • [1] Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease
    Nitta, Kosaku
    Kataoka, Hiroshi
    Manabe, Shun
    Makabe, Shiho
    Akihisa, Taro
    Ushio, Yusuke
    Seki, Momoko
    Tsuchiya, Ken
    Hoshino, Junichi
    Mochizuki, Toshio
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2025, 29 (01) : 75 - 82
  • [2] Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease
    Suwabe, Tatsuya
    Ubara, Yoshifumi
    Oba, Yuki
    Mizuno, Hiroki
    Ikuma, Daisuke
    Yamanouchi, Masayuki
    Sekine, Akinari
    Tanaka, Kiho
    Hasegawa, Eiko
    Hoshino, Junichi
    Sawa, Naoki
    JOURNAL OF NEPHROLOGY, 2023, 36 (04) : 999 - 1010
  • [3] Autosomal dominant polycystic kidney disease
    Cornec-Le Gall, Emilie
    Alam, Ahsan
    Perrone, Ronald D.
    LANCET, 2019, 393 (10174) : 919 - 935
  • [4] Nutritional Status is Associated With Preserved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease
    Lee, Jinwoo
    Ryu, Hyunjin
    Kim, Yong-Chul
    Park, Hayne Cho
    Ahn, Curie
    Lee, Kyu-Beck
    Kim, Yeong Hoon
    Kim, Yaerim
    Han, Seungyeop
    Bae, Eun Hui
    Oh, Kook-Hwan
    Oh, Yun Kyu
    JOURNAL OF RENAL NUTRITION, 2023, 33 (04) : 529 - 537
  • [5] Chronic kidney disease progression in patients with autosomal dominant polycystic kidney disease
    Panizo, Nayara
    Goicoechea, Marian
    Garcia de Vinuesa, Soledad
    Arroyo, David
    Yuste, Claudia
    Rincon, Abraham
    Verdalles, Ursula
    Ruiz-Caro, Caridad
    Quiroga, Borja
    Luno, Jose
    NEFROLOGIA, 2012, 32 (02): : 197 - 205
  • [6] Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease
    van Dijk, MA
    Kamper, AM
    van Veen, S
    Souverijn, JHM
    Blauw, GJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (11) : 2152 - 2157
  • [7] α-lipoic acid in patients with autosomal dominant polycystic kidney disease
    Lai, Silvia
    Petramala, Luigi
    Muscaritoli, Maurizio
    Cianci, Rosario
    Mazzaferro, Sandro
    Mitterhofer, Anna Paola
    Pasquali, Marzia
    D'Ambrosio, Viola
    Carta, Maria
    Ansuini, Matteo
    Ramaccini, Cesarina
    Galani, Alessandro
    Amabile, Maria Ida
    Molfino, Alessio
    Letizia, Claudio
    NUTRITION, 2020, 71
  • [8] Cardiac involvement in patients with Autosomal Dominant Polycystic Kidney Disease and normal renal function after six years of follow-up
    Pietrzak-Nowacka, Maria
    Safranow, Krzysztof
    Czechowska, Malgorzata
    Dutkiewicz, Grazyna
    Gatarska, Ewa
    Ciechanowski, Kazimierz
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2021, 75 : 502 - 510
  • [9] Blood pressure and renal function in autosomal dominant polycystic kidney disease
    Seeman, T
    Sikut, M
    Konrad, M
    Vondrichova, H
    Janda, J
    Scharer, K
    PEDIATRIC NEPHROLOGY, 1997, 11 (05) : 592 - 596
  • [10] Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
    Sans, Laia
    Pascual, Julio
    Radosevic, Aleksandar
    Quintian, Claudia
    Ble, Mireia
    Molina, Lluis
    Mojal, Sergi
    Ballarin, Jose A.
    Torra, Roser
    Fernandez-Llama, Patricia
    MEDICINE, 2016, 95 (49) : e5595